JAX
Mouse Strain Datasheet
B6.Cg-Tg(APP695)3Dbo Tg(PSEN1dE9)S9Dbo/Mmjax
Also Known As: APPswe/PS1dE9, APPswe line C3-3 x PS1dE9 line S-9
These double-transgenic mice show increased amyloid plaque deposition with age along with deficits in cognitive tasks and episodic-like memory tasks.
Donating Investigator
Dr. David R Borchelt, University of Florida
Genetic overview
| Genetic Background | Generation |
|---|---|
|
|
Tg(APP695)3Dbo
| Allele Type |
|---|
| Transgenic (Humanized sequence, Inserted expressed sequence) |
Tg(PSEN1dE9)S9Dbo
| Allele Type |
|---|
| Transgenic (Humanized sequence, Inserted expressed sequence) |
Detailed Description
Double transgenic mice are viable and fertile. At 6 months of age, double-transgenic mice show visible amyloid plaque deposition but are indistinguishable from nontransgenic animals in all cognitive measures. By 18 months, amyloid deposits were much higher in APPswe/PS1dE9 mice with statistically significant but mild decreases in cholinergic markers (cortex and hippocampus) and somatostatin levels (cortex). Performance of older double-transgenic mice is impaired in all cognitive tasks, and deficits in episodic-like memory tasks correlate with total amyloid-beta peptide loads in the brain. Mutant mice, hemizygous for each transgene, and on the C57BL/6J background (N6), have altered EEG (decreased cortical theta activity and increased beta and gamma activity). EEG differences are detected as early as 7 month of age (Wang et al. Brain Res 2002).
Development
Mutant amyloid precursor protein (APPswe) transgenic mice (line C3-3) express a chimeric mouse/human APP-695 with mutations linked to familial Alzheimers disease (KM 593/594 NL; also called K670N/M671L). The C3-3 line was backcrossed to C57BL/6J mice for 10 generations. Presenilin 1 (PSEN1) transgenic mice (line S-9) express human PSEN1 carrying the exon-9-deleted variant (PSEN1dE9) associated with familial Alzheimer's disease. Originally created on a hybrid strain background (C3H/HeJ;C57BL/6J), the S-9 line was backcrossed to C57BL/6J for six generations. Both are under the control of the mouse prion protein (PrP) promoter, directing transgene expression predominantly to CNS neurons. APPswe/PS1dE9 double transgenic mice were produced by mating APP-695 line C3-3 males to PS1dE9 line S-9 females, and then backcrossing double transgenic males to C57BL/6J mice for 10 generations before arriving at the MMRRC at The Jackson Laboratory.
Expression Data
| Expressed Gene | APP695, amyloid beta (A4) precursor protein (chimeric), mouse/human chimera |
|---|---|
| Site of Expression | |
| Expressed Gene | PSEN1, presenilin 1, human |
| Site of Expression |
Control Suggestions
Selected References
- Savonenko A; Xu GM; Melnikova T; Morton JL; Gonzales V; Wong MP; Price DL; Tang F; Markowska AL; Borchelt DR. 2005. Episodic-like memory deficits in the APPswe/PS1dE9 mouse model of Alzheimer's disease: relationships to beta-amyloid deposition and neurotransmitter abnormalities. Neurobiol Dis 18(3):602-17. PubMed: 15755686MGI: J:104236
Tg(APP695)3Dbo
Allele Symbol: Tg(APP695)3Dbo
| Allele Name | transgene insertion 3, David R Borchelt |
|---|---|
| Allele Type | Transgenic (Humanized sequence, Inserted expressed sequence) |
| Allele Synonym(s) | APP695; APP695swe; APPswe; Mo/HuAPPswe; line C3-3 |
| Gene Symbol and Name | Tg(APP695)3Dbo, transgene insertion 3, David R Borchelt |
| Gene Synonym(s) | APP695; APP695swe; APPswe; Mo/HuAPPswe; line C3-3 |
| Promoter | Prn, prion protein readthrough transcript, mouse, laboratory |
| Expressed Gene | APP695, amyloid beta (A4) precursor protein (chimeric), mouse/human chimera |
| Strain of Origin | (C57BL/6J x C3H/HeJ)F2 |
| Chromosome | UN |
| General Note | Three transgenic lines were generated and designated by the authors lines Q2-2, E1-2 (Tg(Prnp-App/APPswe)E1-2Dbo) and C3-3. This line was generated from founder number C3-3. Transgenic mice develop amyloid deposits in brain tissue by 18-20 months of age. Transgenic mice that are also transgenic for Tg(PSEN1)5Dboexpress both human presenilin 1 (A246E variant) and a chimeric amyloid precursor protein (APPSwe) under direction of the mouse prion protein promoter. Elevated levels of the AB1-42(43) peptide are detected in brain homogenates. By nine months of age, histological examination of brain tissue from these mice reveals numerous amyloid deposits resembling those observed in the brains of patients with Alzheimer's disease (AD). The number of amyloid deposits increases dramatically between the ages of 10 and 12 months. |
| Molecular Note | The transgene is composed of a cDNA encoding a chimeric APP protein regulated by the mouse prion promoter. The chimeric APP molecule was created by replacing sequences encoding the Abeta domain of a 695 amino acid isoform of the murine sequence with the cognate sequences of the human gene (mutations K595N, M596L). The human mutations are found in familial Alzheimer's disease. Transgene expression was observed in the brain and heart by Western blot analysis using a monoclonal antibody recognizing the human Abeta region. |
| Mutations Made By | Dr. David Borchelt, University of Florida |
Tg(PSEN1dE9)S9Dbo
Allele Symbol: Tg(PSEN1dE9)S9Dbo
| Allele Name | transgene insertion S9, David R Borchelt |
|---|---|
| Allele Type | Transgenic (Humanized sequence, Inserted expressed sequence) |
| Allele Synonym(s) | PS1 deltaE9; PS1 transgene (line S-9); PS1-deltaE9; PS1dE9 transgene; PS1deltaE9 (line S-9); deltaE9; huPS1deltaE9; line S-9 |
| Gene Symbol and Name | Tg(PSEN1dE9)S9Dbo, transgene insertion S9, David R Borchelt |
| Gene Synonym(s) | PS1 deltaE9; PS1 transgene (line S-9); PS1-deltaE9; PS1dE9 transgene; PS1deltaE9 (line S-9); deltaE9; huPS1deltaE9; line S-9 |
| Promoter | Prnp, prion protein, mouse, laboratory |
| Expressed Gene | PSEN1, presenilin 1, human |
| Strain of Origin | (C57BL/6J x C3H/HeJ)F2 |
| Chromosome | UN |
| General Note | The deltaE9 PSEN1 protein variant fails to undergo endoproteolysis in cultured lymphoblasts from an affected human carrier and instead accumulates as the full-length, 40 kDa mutant protein (J:34323). Similarly, immunoblotting of of cortical and hippocampal extracts from transgenic mice under conditions that distinguish mouse and human full-length PSEN1 and their endoproteolytic derivatives demonstrates failure of the transgenic protein to undergo endoproteolysis. (J:104147) The amount of full-length mutant human PSEN1 in brains of deltaE9 PSEN1 transgenic mice exceeds by ~60% the cumulative amount of the full-length human PSEN1 and its N-terminal derivative in brains of transgenic mice expressing wild-type human PSEN1. (J:104147) |
| Molecular Note | The coding sequence of the transgene is derived from the cDNA of the familial Alzheimer disease- (FAD-) associated deltaE9 variant of human presenilin 1, which has a splice acceptor mutation upstream of exon 9 that results in a protein lacking amino acids 290-319. The mutant cDNA replaces the coding region of the mouse prion protein (Prp) gene in a construct that contains ~6 kb of genomic DNA upstream of the primary PRP translation start site and includes the noncoding first exon and first intron and, following the inserted PSEN1 sequence, ~3 kb of 3' untranslated sequence; this construct has been shown to drive expression in both neurons and glial cells of the central nervous system (CNS). |
| Mutations Made By | Dr. David Borchelt, University of Florida |
Disease Terms
Research Areas By Genotype
This mouse can be used to support research in many areas including:
- Neurobiology Research
- Alzheimer's Disease
- APP and PSEN1 mutants
- Presenilin mutants
- strains expressing mutant APP
- Behavioral and Learning Defects
- Alzheimer's Disease
Genotype: Tg(APP695)3Dbo related
- Neurobiology Research
- Alzheimer's Disease
- Neurodegeneration
Mammalian Phenotype Terms by Genotype
Genotype: Tg(APP695)3Dbo/0 Tg(PSEN1dE9)S9Dbo/0
B6.Cg-Tg(APP695)3Dbo Tg(PSEN1dE9)S9Dbo/Mmjax
nervous system phenotype
- amyloid beta deposits
- (MGI Ref ID J:157228)
homeostasis/metabolism phenotype
- amyloid beta deposits
- (MGI Ref ID J:157228)
The following phenotype information is associated with a similar, but not exact match to this JAX® Mice strain
Genotype: Tg(APP695)3Dbo/0 Tg(PSEN1dE9)S9Dbo/0
Not Specified
nervous system phenotype
- abnormal amacrine cell morphology
- distribution of amacrine cell processes is disrupted as determined by syntaxin 1 staining (MGI Ref ID J:139070)
- abnormal microglial cell morphology
- increase in microglial cell activity in retina is observed in 12-15 month old transgenics (MGI Ref ID J:139070)
- microglia density, but not cell body size, is increased in transgenics (MGI Ref ID J:139070)
- microglia processes in the retina are thicker and display a dendritic-like appearance as compared to control (MGI Ref ID J:139070)
- amyloid beta deposits
- 100% of females and 75% of males have plaques in retina by 15-16 months (MGI Ref ID J:139070)
- plaque size ranges from 5-20 um, larger plaques are observed at 15-16 months (MGI Ref ID J:139070)
- plaques appear earlier in females than in males and increase in number over time (MGI Ref ID J:139070)
- plaques have radial branches with a central core (MGI Ref ID J:139070)
- thioflavine-S positive plaques are observed in the retina beginning at 12 months of age (MGI Ref ID J:139070)
vision/eye phenotype
- abnormal amacrine cell morphology
- distribution of amacrine cell processes is disrupted as determined by syntaxin 1 staining (MGI Ref ID J:139070)
- abnormal eye electrophysiology
- abnormal retina morphology
- most plaques (34.7% and 41% respectively) are found in the inner and outer plexiform layers (MGI Ref ID J:139070)
- thickness of the retinal nuclear layers is similar to control, suggesting that there is no obvious neuronal cell loss (MGI Ref ID J:139070)
- thioflavine-S positive plaques are observed in the retina beginning at 12 months of age (MGI Ref ID J:139070)
- abnormal retinal inner plexiform layer morphology
- abnormal retinal outer plexiform layer morphology
immune system phenotype
- abnormal microglial cell morphology
- increase in microglial cell activity in retina is observed in 12-15 month old transgenics (MGI Ref ID J:139070)
- microglia density, but not cell body size, is increased in transgenics (MGI Ref ID J:139070)
- microglia processes in the retina are thicker and display a dendritic-like appearance as compared to control (MGI Ref ID J:139070)
hematopoietic system phenotype
- abnormal microglial cell morphology
- increase in microglial cell activity in retina is observed in 12-15 month old transgenics (MGI Ref ID J:139070)
- microglia density, but not cell body size, is increased in transgenics (MGI Ref ID J:139070)
- microglia processes in the retina are thicker and display a dendritic-like appearance as compared to control (MGI Ref ID J:139070)
homeostasis/metabolism phenotype
- amyloid beta deposits
- 100% of females and 75% of males have plaques in retina by 15-16 months (MGI Ref ID J:139070)
- plaque size ranges from 5-20 um, larger plaques are observed at 15-16 months (MGI Ref ID J:139070)
- plaques appear earlier in females than in males and increase in number over time (MGI Ref ID J:139070)
- plaques have radial branches with a central core (MGI Ref ID J:139070)
- thioflavine-S positive plaques are observed in the retina beginning at 12 months of age (MGI Ref ID J:139070)
Genotype: Tg(APP695)3Dbo/0 Tg(PSEN1dE9)S9Dbo/0
involves: 129S1/Sv * 129X1/SvJ * C3H/HeJ * C57BL/6J
behavior/neurological phenotype
- abnormal spatial learning
- mice travel shorter distance in open-field and show less activity or excursions into central area; mice remain near periphery of apparatus rather than entering open center of field (MGI Ref ID J:123534)
- abnormal spatial reference memory
- 16-18 month-old mice swim farther to find platform and spend less time in platform vicinity than controls (MGI Ref ID J:123534)
- behavior/neurological phenotype
- (MGI Ref ID J:123534)
nervous system phenotype
- amyloid beta deposits
- one month following neuron injection with virus expressing short hairpin RNA to silence Bace1, there is a 38% reduction in amyloid beta burden in hippocampus compared to uninjected hippocampus (MGI Ref ID J:123534)
homeostasis/metabolism phenotype
- amyloid beta deposits
- one month following neuron injection with virus expressing short hairpin RNA to silence Bace1, there is a 38% reduction in amyloid beta burden in hippocampus compared to uninjected hippocampus (MGI Ref ID J:123534)
- amyloidosis
- mice display amyloid beta aggregates at 12 and 20 months (MGI Ref ID J:123534)
Genotype: Tg(APP695)3Dbo/0 Tg(PSEN1dE9)S9Dbo/0
involves: C3H/HeJ * C57BL/6J
nervous system phenotype
- amyloid beta deposits
- 150% increase in amyloid beta peptide 42 (MGI Ref ID J:87691)
- at 7 months of age, mice exhibit amyloid plaques in the hippocampus and cortex (MGI Ref ID J:104236)
- develops diffuse, compact, birefringent congophilic plaques in cortex and hippocampus (MGI Ref ID J:87691)
- ratio of amyloid beta peptide 40:42 is 0.75:1 (MGI Ref ID J:87691)
homeostasis/metabolism phenotype
- amyloid beta deposits
- 150% increase in amyloid beta peptide 42 (MGI Ref ID J:87691)
- at 7 months of age, mice exhibit amyloid plaques in the hippocampus and cortex (MGI Ref ID J:104236)
- develops diffuse, compact, birefringent congophilic plaques in cortex and hippocampus (MGI Ref ID J:87691)
- ratio of amyloid beta peptide 40:42 is 0.75:1 (MGI Ref ID J:87691)
References
- Savonenko A; Xu GM; Melnikova T; Morton JL; Gonzales V; Wong MP; Price DL; Tang F; Markowska AL; Borchelt DR. 2005. Episodic-like memory deficits in the APPswe/PS1dE9 mouse model of Alzheimer's disease: relationships to beta-amyloid deposition and neurotransmitter abnormalities. Neurobiol Dis 18(3):602-17. PubMed: 15755686MGI: J:104236
Additional References
- Verret L; Jankowsky JL; Xu GM; Borchelt DR; Rampon C. 2007. Alzheimer's-type amyloidosis in transgenic mice impairs survival of newborn neurons derived from adult hippocampal neurogenesis. J Neurosci 27(25):6771-80. PubMed: 17581964MGI: J:122001
Additional - Tg(APP695)3Dbo related
- Bailey AR; Hou H; Obregon DF; Tian J; Zhu Y; Zou Q; Nikolic WV; Bengtson M; Mori T; Murphy T; Tan J. 2012. Aberrant T-lymphocyte development and function in mice overexpressing human soluble amyloid precursor protein-alpha: implications for autism. FASEB J 26(3):1040-51. PubMed: 22085641MGI: J:182808
- Bailey AR; Hou H; Song M; Obregon DF; Portis S; Barger S; Shytle D; Stock S; Mori T; Sanberg PG; Murphy T; Tan J. 2013. GFAP expression and social deficits in transgenic mice overexpressing human sAPPalpha. Glia 61(9):1556-69. PubMed: 23840007MGI: J:199441
- Boissonneault V; Plante I; Rivest S; Provost P. 2009. MicroRNA-298 and microRNA-328 regulate expression of mouse beta-amyloid precursor protein-converting enzyme 1. J Biol Chem 284(4):1971-81. PubMed: 18986979MGI: J:146980
- Borchelt DR; Davis J; Fischer M; Lee MK; Slunt HH; Ratovitsky T; Regard J; Copeland NG; Jenkins NA; Sisodia SS; Price DL. 1996. A vector for expressing foreign genes in the brains and hearts of transgenic mice. Genet Anal 13(6):159-63. PubMed: 9117892MGI: J:80782
- Borchelt DR; Ratovitski T; van Lare J; Lee MK; Gonzales V; Jenkins NA; Copeland NG; Price DL; Sisodia SS. 1997. Accelerated amyloid deposition in the brains of transgenic mice coexpressing mutant presenilin 1 and amyloid precursor proteins. Neuron 19(4):939-45. PubMed: 9354339MGI: J:43788
- Borchelt DR; Thinakaran G; Eckman CB; Lee MK; Davenport F; Ratovitsky T; Prada CM; Kim G; Seekins S; Yager D; Slunt HH; Wang R; Seeger M; Levey AI; Gandy SE; Copeland NG; Jenkins NA; Price DL; Younkin SG; Sisodia SS. 1996. Familial Alzheimer's disease-linked presenilin 1 variants elevate Abeta1-42/1-40 ratio in vitro and in vivo. Neuron 17(5):1005-13. PubMed: 8938131MGI: J:80882
- Cai D; Zhong M; Wang R; Netzer WJ; Shields D; Zheng H; Sisodia SS; Foster DA; Gorelick FS; Xu H; Greengard P. 2006. Phospholipase D1 corrects impaired betaAPP trafficking and neurite outgrowth in familial Alzheimer's disease-linked presenilin-1 mutant neurons. Proc Natl Acad Sci U S A 103(6):1936-40. PubMed: 16449385MGI: J:106075
- Cai Y; Xue ZQ; Zhang XM; Li MB; Wang H; Luo XG; Cai H; Yan XX. 2012. An age-related axon terminal pathology around the first olfactory relay that involves amyloidogenic protein overexpression without plaque formation. Neuroscience 215:160-73. PubMed: 22542680MGI: J:192436
- Dodson SE; Andersen OM; Karmali V; Fritz JJ; Cheng D; Peng J; Levey AI; Willnow TE; Lah JJ. 2008. Loss of LR11/SORLA enhances early pathology in a mouse model of amyloidosis: evidence for a proximal role in Alzheimer's disease. J Neurosci 28(48):12877-86. PubMed: 19036982MGI: J:142501
- Dolev I; Fogel H; Milshtein H; Berdichevsky Y; Lipstein N; Brose N; Gazit N; Slutsky I. 2013. Spike bursts increase amyloid-beta 40/42 ratio by inducing a presenilin-1 conformational change. Nat Neurosci 16(5):587-95. PubMed: 23563578MGI: J:197603
- El-Amouri SS; Zhu H; Yu J; Marr R; Verma IM; Kindy MS. 2008. Neprilysin: an enzyme candidate to slow the progression of Alzheimer's disease. Am J Pathol 172(5):1342-54. PubMed: 18403590MGI: J:134308
- Fernandez-Martos CM; King AE; Atkinson RA; Woodhouse A; Vickers JC. 2015. Neurofilament light gene deletion exacerbates amyloid, dystrophic neurite, and synaptic pathology in the APP/PS1 transgenic model of Alzheimer's disease. Neurobiol Aging 36(10):2757-67. PubMed: 26344875MGI: J:232249
- Filali M; Lalonde R. 2009. Age-related cognitive decline and nesting behavior in an APPswe/PS1 bigenic model of Alzheimer's disease. Brain Res 1292:93-9. PubMed: 19643098MGI: J:157207
- Filali M; Lalonde R; Rivest S. 2008. Cognitive and non-cognitive behaviors in an APPswe/PS1 bigenic model of Alzheimer's disease. Genes Brain Behav 8(2):143-8. PubMed: 19077180MGI: J:142183
- Filali M; Lalonde R; Rivest S. 2011. Subchronic memantine administration on spatial learning, exploratory activity, and nest-building in an APP/PS1 mouse model of Alzheimer's disease. Neuropharmacology 60(6):930-6. PubMed: 21281652MGI: J:178504
- Gao L; Chen X; Tang Y; Zhao J; Li Q; Fan X; Xu H; Yin ZQ. 2015. Neuroprotective effect of memantine on the retinal ganglion cells of APPswe/PS1DeltaE9 mice and its immunomodulatory mechanisms. Exp Eye Res 135:47-58. PubMed: 25912193MGI: J:230333
- Garcia-Alloza M; Dodwell SA; Meyer-Luehmann M; Hyman BT; Bacskai BJ. 2006. Plaque-derived oxidative stress mediates distorted neurite trajectories in the Alzheimer mouse model. J Neuropathol Exp Neurol 65(11):1082-9. PubMed: 17086105MGI: J:120918
- Gureviciene I; Ikonen S; Gurevicius K; Sarkaki A; van Groen T; Pussinen R; Ylinen A; Tanila H. 2004. Normal induction but accelerated decay of LTP in APP + PS1 transgenic mice. Neurobiol Dis 15(2):188-95. PubMed: 15006688MGI: J:128772
- Helft J; Manicassamy B; Guermonprez P; Hashimoto D; Silvin A; Agudo J; Brown BD; Schmolke M; Miller JC; Leboeuf M; Murphy KM; Garcia-Sastre A; Merad M. 2012. Cross-presenting CD103+ dendritic cells are protected from influenza virus infection. J Clin Invest 122(11):4037-47. PubMed: 23041628MGI: J:193561
- Horiuchi H; Parajuli B; Wang Y; Azuma YT; Mizuno T; Takeuchi H; Suzumura A. 2015. Interleukin-19 acts as a negative autocrine regulator of activated microglia. PLoS One 10(3):e0118640. PubMed: 25794104MGI: J:229575
- Huang HJ; Liang KC; Ke HC; Chang YY; Hsieh-Li HM. 2011. Long-term social isolation exacerbates the impairment of spatial working memory in APP/PS1 transgenic mice. Brain Res 1371:150-60. PubMed: 21114967MGI: J:170247
- Iivonen H; Nurminen L; Harri M; Tanila H; Puolivali J. 2003. Hypothermia in mice tested in Morris water maze. Behav Brain Res 141(2):207-13. PubMed: 12742257MGI: J:130974
- Jankowsky JL; Fadale DJ; Anderson J; Xu GM; Gonzales V; Jenkins NA; Copeland NG; Lee MK; Younkin LH; Wagner SL; Younkin SG; Borchelt DR. 2004. Mutant presenilins specifically elevate the levels of the 42 residue beta-amyloid peptide in vivo: evidence for augmentation of a 42-specific gamma secretase. Hum Mol Genet 13(2):159-70. PubMed: 14645205MGI: J:87691
- Jankowsky JL; Melnikova T; Fadale DJ; Xu GM; Slunt HH; Gonzales V; Younkin LH; Younkin SG; Borchelt DR; Savonenko AV. 2005. Environmental enrichment mitigates cognitive deficits in a mouse model of Alzheimer's disease. J Neurosci 25(21):5217-24. PubMed: 15917461MGI: J:98541
- Jankowsky JL; Slunt HH; Gonzales V; Jenkins NA; Copeland NG; Borchelt DR. 2004. APP processing and amyloid deposition in mice haplo-insufficient for presenilin 1. Neurobiol Aging 25(7):885-92. PubMed: 15212842MGI: J:102351
- Kalesnykas G; Roschier U; Puolivali J; Wang J; Miettinen R. 2005. The effect of aging on the subcellular distribution of estrogen receptor-alpha in the cholinergic neurons of transgenic and wild-type mice. Eur J Neurosci 21(5):1437-42. PubMed: 15813954MGI: J:101077
- Kamphuis W; Kooijman L; Orre M; Stassen O; Pekny M; Hol EM. 2015. GFAP and vimentin deficiency alters gene expression in astrocytes and microglia in wild-type mice and changes the transcriptional response of reactive glia in mouse model for Alzheimer's disease. Glia 63(6):1036-56. PubMed: 25731615MGI: J:221193
- Kanekiyo T; Cirrito JR; Liu CC; Shinohara M; Li J; Schuler DR; Shinohara M; Holtzman DM; Bu G. 2013. Neuronal clearance of amyloid-beta by endocytic receptor LRP1. J Neurosci 33(49):19276-83. PubMed: 24305823MGI: J:204149
- Kanekiyo T; Liu CC; Shinohara M; Li J; Bu G. 2012. LRP1 in brain vascular smooth muscle cells mediates local clearance of Alzheimer's amyloid-beta. J Neurosci 32(46):16458-65. PubMed: 23152628MGI: J:192453
- Ke HC; Huang HJ; Liang KC; Hsieh-Li HM. 2011. Selective improvement of cognitive function in adult and aged APP/PS1 transgenic mice by continuous non-shock treadmill exercise. Brain Res 1403:1-11. PubMed: 21689809MGI: J:174067
- Khan UA; Liu L; Provenzano FA; Berman DE; Profaci CP; Sloan R; Mayeux R; Duff KE; Small SA. 2014. Molecular drivers and cortical spread of lateral entorhinal cortex dysfunction in preclinical Alzheimer's disease. Nat Neurosci 17(2):304-11. PubMed: 24362760MGI: J:208008
- Laird FM; Cai H; Savonenko AV; Farah MH; He K; Melnikova T; Wen H; Chiang HC; Xu G; Koliatsos VE; Borchelt DR; Price DL; Lee HK; Wong PC. 2005. BACE1, a major determinant of selective vulnerability of the brain to amyloid-beta amyloidogenesis, is essential for cognitive, emotional, and synaptic functions. J Neurosci 25(50):11693-709. PubMed: 16354928MGI: J:123534
- Lazarov O; Morfini GA; Pigino G; Gadadhar A; Chen X; Robinson J; Ho H; Brady ST; Sisodia SS. 2007. Impairments in fast axonal transport and motor neuron deficits in transgenic mice expressing familial Alzheimer's disease-linked mutant presenilin 1. J Neurosci 27(26):7011-20. PubMed: 17596450MGI: J:122975
- Lee GD; Aruna JH; Barrett PM; Lei DL; Ingram DK; Mouton PR. 2005. Stereological analysis of microvascular parameters in a double transgenic model of Alzheimer's disease. Brain Res Bull 65(4):317-22. PubMed: 15811597MGI: J:135436
- Lesuisse C; Xu G; Anderson J; Wong M; Jankowsky J; Holtz G; Gonzalez V; Wong PC; Price DL; Tang F; Wagner S; Borchelt DR. 2001. Hyper-expression of human apolipoprotein E4 in astroglia and neurons does not enhance amyloid deposition in transgenic mice. Hum Mol Genet 10(22):2525-37. PubMed: 11709540MGI: J:72987
- Li G; Zou L; Jack CR Jr; Yang Y; Yang ES. 2007. Neuroprotective effect of Coenzyme Q10 on ischemic hemisphere in aged mice with mutations in the amyloid precursor protein. Neurobiol Aging 28(6):877-82. PubMed: 16806588MGI: J:121939
- Li L; Zhang X; Yang D; Luo G; Chen S; Le W. 2009. Hypoxia increases Abeta generation by altering beta- and gamma-cleavage of APP. Neurobiol Aging 30(7):1091-8. PubMed: 18063223MGI: J:152965
- Liang C; Zhu H; Xu Y; Huang L; Ma C; Deng W; Liu Y; Qin C. 2012. MicroRNA-153 negatively regulates the expression of amyloid precursor protein and amyloid precursor-like protein 2. Brain Res 1455:103-13. PubMed: 22510281MGI: J:186457
- Liu L; Ikonen S; Heikkinen T; Heikkila M; Puolivali J; van Groen T; Tanila H. 2002. Effects of fimbria-fornix lesion and amyloid pathology on spatial learning and memory in transgenic APP+PS1 mice. Behav Brain Res 134(1-2):433-45. PubMed: 12191831MGI: J:129807
- Liu L; Tapiola T; Herukka SK; Heikkila M; Tanila H. 2003. Abeta levels in serum, CSF and brain, and cognitive deficits in APP + PS1 transgenic mice. Neuroreport 14(1):163-6. PubMed: 12544850MGI: J:89843
- Liu Y; Yoo MJ; Savonenko A; Stirling W; Price DL; Borchelt DR; Mamounas L; Lyons WE; Blue ME; Lee MK. 2008. Amyloid pathology is associated with progressive monoaminergic neurodegeneration in a transgenic mouse model of Alzheimer's disease. J Neurosci 28(51):13805-14. PubMed: 19091971MGI: J:143521
- Lopez JR; Lyckman A; Oddo S; Laferla FM; Querfurth HW; Shtifman A. 2008. Increased intraneuronal resting [Ca2+] in adult Alzheimer's disease mice. J Neurochem 105(1):262-71. PubMed: 18021291MGI: J:141555
- Luo H; Wu Q; Ye X; Xiong Y; Zhu J; Xu J; Diao Y; Zhang D; Wang M; Qiu J; Miao J; Zhang W; Wan J. 2014. Genome-wide analysis of miRNA signature in the APPswe/PS1DeltaE9 mouse model of alzheimer's disease. PLoS One 9(8):e101725. PubMed: 25148207MGI: J:221085
- Manczak M; Reddy PH. 2012. Abnormal interaction between the mitochondrial fission protein Drp1 and hyperphosphorylated tau in Alzheimer's disease neurons: implications for mitochondrial dysfunction and neuronal damage. Hum Mol Genet 21(11):2538-47. PubMed: 22367970MGI: J:183771
- Melnikova T; Savonenko A; Wang Q; Liang X; Hand T; Wu L; Kaufmann WE; Vehmas A; Andreasson KI. 2006. Cycloxygenase-2 activity promotes cognitive deficits but not increased amyloid burden in a model of Alzheimer's disease in a sex-dimorphic pattern. Neuroscience 141(3):1149-62. PubMed: 16753269MGI: J:111748
- Mitew S; Kirkcaldie MT; Dickson TC; Vickers JC. 2013. Altered synapses and gliotransmission in Alzheimer's disease and AD model mice. Neurobiol Aging 34(10):2341-51. PubMed: 23643146MGI: J:211729
- Montgomery KS; Simmons RK; Edwards G 3rd; Nicolle MM; Gluck MA; Myers CE; Bizon JL. 2011. Novel age-dependent learning deficits in a mouse model of Alzheimer's disease: Implications for translational research. Neurobiol Aging 32(7):1273-85. PubMed: 19720431MGI: J:173732
- Naert G; Rivest S. 2011. CC Chemokine Receptor 2 Deficiency Aggravates Cognitive Impairments and Amyloid Pathology in a Transgenic Mouse Model of Alzheimer's Disease. J Neurosci 31(16):6208-20. PubMed: 21508244MGI: J:171601
- Nikolajsen GN; Jensen MS; West MJ. 2011. Cholinergic axon length reduced by 300 meters in the brain of an Alzheimer mouse model. Neurobiol Aging 32(11):1927-31. PubMed: 21752495MGI: J:176689
- Nikolajsen GN; Kotynski KA; Jensen MS; West MJ. 2015. Quantitative analysis of the capillary network of aged APPswe/PS1dE9 transgenic mice. Neurobiol Aging 36(11):2954-62. PubMed: 26364735MGI: J:232245
- Oh ES; Savonenko AV; King JF; Fangmark Tucker SM; Rudow GL; Xu G; Borchelt DR; Troncoso JC. 2009. Amyloid precursor protein increases cortical neuron size in transgenic mice. Neurobiol Aging 30(8):1238-44. PubMed: 18304698MGI: J:152955
- Ojala J; Alafuzoff I; Herukka SK; van Groen T; Tanila H; Pirttila T. 2009. Expression of interleukin-18 is increased in the brains of Alzheimer's disease patients. Neurobiol Aging 30(2):198-209. PubMed: 17658666MGI: J:145816
- Orre M; Kamphuis W; Osborn LM; Jansen AH; Kooijman L; Bossers K; Hol EM. 2014. Isolation of glia from Alzheimer's mice reveals inflammation and dysfunction. Neurobiol Aging 35(12):2746-60. PubMed: 25002035MGI: J:218071
- Paban V; Manrique C; Filali M; Maunoir-Regimbal S; Fauvelle F; Alescio-Lautier B. 2014. Therapeutic and preventive effects of methylene blue on Alzheimer's disease pathology in a transgenic mouse model. Neuropharmacology 76 Pt A:68-79. PubMed: 23891615MGI: J:214171
- Perez SE; Dar S; Ikonomovic MD; DeKosky ST; Mufson EJ. 2007. Cholinergic forebrain degeneration in the APPswe/PS1DeltaE9 transgenic mouse. Neurobiol Dis 28(1):3-15. PubMed: 17662610MGI: J:134818
- Perez SE; Lazarov O; Koprich JB; Chen EY; Rodriguez-Menendez V; Lipton JW; Sisodia SS; Mufson EJ. 2005. Nigrostriatal dysfunction in familial Alzheimer's disease-linked APPswe/PS1DeltaE9 transgenic mice. J Neurosci 25(44):10220-9. PubMed: 16267229MGI: J:102362
- Perez SE; Lumayag S; Kovacs B; Mufson EJ; Xu S. 2008. {beta}-Amyloid Deposition and Functional Impairment in the Retina of the APPswe/PS1{Delta}E9 Transgenic Mouse Model of Alzheimer's Disease. Invest Ophthalmol Vis Sci 50(2):793-800. PubMed: 18791173MGI: J:139070
- Pimentel-Coelho PM; Michaud JP; Rivest S. 2013. Effects of mild chronic cerebral hypoperfusion and early amyloid pathology on spatial learning and the cellular innate immune response in mice. Neurobiol Aging 34(3):679-93. PubMed: 22819135MGI: J:194432
- Pistell PJ; Zhu M; Ingram DK. 2008. Acquisition of conditioned taste aversion is impaired in the amyloid precursor protein/presenilin 1 mouse model of Alzheimer's disease. Neuroscience 152(3):594-600. PubMed: 18304749MGI: J:135640
- Popovic M; Caballero-Bleda M; Kadish I; Van Groen T. 2008. Subfield and layer-specific depletion in calbindin-D28K, calretinin and parvalbumin immunoreactivity in the dentate gyrus of amyloid precursor protein/presenilin 1 transgenic mice. Neuroscience 155(1):182-91. PubMed: 18583063MGI: J:140778
- Reinders NR; Pao Y; Renner MC; da Silva-Matos CM; Lodder TR; Malinow R; Kessels HW. 2016. Amyloid-beta effects on synapses and memory require AMPA receptor subunit GluA3. Proc Natl Acad Sci U S A 113(42):E6526-E6534. PubMed: 27708157MGI: J:238628
- Richard KL; Filali M; Prefontaine P; Rivest S. 2008. Toll-like receptor 2 acts as a natural innate immune receptor to clear amyloid beta 1-42 and delay the cognitive decline in a mouse model of Alzheimer's disease. J Neurosci 28(22):5784-93. PubMed: 18509040MGI: J:136387
- Ricoy UM; Mao P; Manczak M; Reddy PH; Frerking ME. 2011. A transgenic mouse model for Alzheimer's disease has impaired synaptic gain but normal synaptic dynamics. Neurosci Lett 500(3):212-5. PubMed: 21741442MGI: J:174545
- Rodriguez JJ; Olabarria M; Chvatal A; Verkhratsky A. 2009. Astroglia in dementia and Alzheimer's disease. Cell Death Differ 16(3):378-85. PubMed: 19057621MGI: J:158080
- Savonenko AV; Xu GM; Price DL; Borchelt DR; Markowska AL. 2003. Normal cognitive behavior in two distinct congenic lines of transgenic mice hyperexpressing mutant APP SWE. Neurobiol Dis 12(3):194-211. PubMed: 12742740MGI: J:109847
- Sheline YI; West T; Yarasheski K; Swarm R; Jasielec MS; Fisher JR; Ficker WD; Yan P; Xiong C; Frederiksen C; Grzelak MV; Chott R; Bateman RJ; Morris JC; Mintun MA; Lee JM; Cirrito JR. 2014. An antidepressant decreases CSF Abeta production in healthy individuals and in transgenic AD mice. Sci Transl Med 6(236):236re4. PubMed: 24828079MGI: J:215342
- Simard AR; Soulet D; Gowing G; Julien JP; Rivest S. 2006. Bone marrow-derived microglia play a critical role in restricting senile plaque formation in Alzheimer's disease. Neuron 49(4):489-502. PubMed: 16476660MGI: J:107605
- Soderman A; Mikkelsen JD; West MJ; Christensen DZ; Jensen MS. 2011. Activation of nicotinic alpha(7) acetylcholine receptor enhances long term potentation in wild type mice but not in APP(swe)/PS1DeltaE9 mice. Neurosci Lett 487(3):325-9. PubMed: 20974225MGI: J:168638
- Soderman A; Thomsen MS; Hansen HH; Nielsen EO; Jensen MS; West MJ; Mikkelsen JD. 2008. The nicotinic alpha7 acetylcholine receptor agonist ssr180711 is unable to activate limbic neurons in mice overexpressing human amyloid-beta1-42. Brain Res 1227:240-7. PubMed: 18619425MGI: J:139987
- Son SM; Jung ES; Shin HJ; Byun J; Mook-Jung I. 2012. Abeta-induced formation of autophagosomes is mediated by RAGE-CaMKKbeta-AMPK signaling. Neurobiol Aging 33(5):1006.e11-23. PubMed: 22048125MGI: J:188183
- Stokin GB; Lillo C; Falzone TL; Brusch RG; Rockenstein E; Mount SL; Raman R; Davies P; Masliah E; Williams DS; Goldstein LS. 2005. Axonopathy and transport deficits early in the pathogenesis of Alzheimer's disease. Science 307(5713):1282-8. PubMed: 15731448MGI: J:96346
- Sun X; Wu Y; Gu M; Zhang Y. 2014. miR-342-5p decreases ankyrin G levels in Alzheimer's disease transgenic mouse models. Cell Rep 6(2):264-70. PubMed: 24440716MGI: J:208793
- Szapacs ME; Numis AL; Andrews AM. 2004. Late onset loss of hippocampal 5-HT and NE is accompanied by increases in BDNF protein expression in mice co-expressing mutant APP and PS1. Neurobiol Dis 16(3):572-80. PubMed: 15262269MGI: J:131666
- Tang J; Song M; Wang Y; Fan X; Xu H; Bai Y. 2009. Noggin and BMP4 co-modulate adult hippocampal neurogenesis in the APP(swe)/PS1(DeltaE9) transgenic mouse model of Alzheimer's disease. Biochem Biophys Res Commun 385(3):341-5. PubMed: 19463786MGI: J:150675
- Turdi S; Guo R; Huff AF; Wolf EM; Culver B; Ren J. 2009. Cardiomyocyte contractile dysfunction in the APPswe/PS1dE9 mouse model of Alzheimer's disease. PLoS One 4(6):e6033. PubMed: 19551139MGI: J:150191
- Veeraraghavalu K; Zhang C; Zhang X; Tanzi RE; Sisodia SS. 2014. Age-dependent, non-cell-autonomous deposition of amyloid from synthesis of beta-amyloid by cells other than excitatory neurons. J Neurosci 34(10):3668-73. PubMed: 24599465MGI: J:209619
- Vepsalainen S; Hiltunen M; Helisalmi S; Wang J; van Groen T; Tanila H; Soininen H. 2008. Increased expression of Abeta degrading enzyme IDE in the cortex of transgenic mice with Alzheimer's disease-like neuropathology. Neurosci Lett 438(2):216-20. PubMed: 18455870MGI: J:136710
- Verret L; Jankowsky JL; Xu GM; Borchelt DR; Rampon C. 2007. Alzheimer's-type amyloidosis in transgenic mice impairs survival of newborn neurons derived from adult hippocampal neurogenesis. J Neurosci 27(25):6771-80. PubMed: 17581964MGI: J:122001
- Wang CM; Devries S; Camboni M; Glass M; Martin PT. 2010. Immunization with the SDPM1 peptide lowers amyloid plaque burden and improves cognitive function in the APPswePSEN1(A246E) transgenic mouse model of Alzheimer's disease. Neurobiol Dis 39(3):409-22. PubMed: 20493257MGI: J:163033
- Wang J; Ikonen S; Gurevicius K; Van Groen T; Tanila H. 2003. Altered auditory-evoked potentials in mice carrying mutated human amyloid precursor protein and presenilin-1 transgenes. Neuroscience 116(2):511-7. PubMed: 12559106MGI: J:128594
- Wang J; Ikonen S; Gurevicius K; van Groen T; Tanila H. 2002. Alteration of cortical EEG in mice carrying mutated human APP transgene. Brain Res 943(2):181-90. PubMed: 12101040MGI: J:78111
- Wang J; Tanila H; Puolivali J; Kadish I; van Groen T. 2003. Gender differences in the amount and deposition of amyloidbeta in APPswe and PS1 double transgenic mice. Neurobiol Dis 14(3):318-27. PubMed: 14678749MGI: J:100956
- Wang X; Liu P; Zhu H; Xu Y; Ma C; Dai X; Huang L; Liu Y; Zhang L; Qin C. 2009. miR-34a, a microRNA up-regulated in a double transgenic mouse model of Alzheimer's disease, inhibits bcl2 translation. Brain Res Bull 80(4-5):268-73. PubMed: 19683563MGI: J:186827
- Wasik U; Schneider G; Mietelska-Porowska A; Mazurkiewicz M; Fabczak H; Weis S; Zabke C; Harrington CR; Filipek A; Niewiadomska G. 2013. Calcyclin binding protein and Siah-1 interacting protein in Alzheimer's disease pathology: neuronal localization and possible function. Neurobiol Aging 34(5):1380-8. PubMed: 23260124MGI: J:203376
- Xiang Z; Ho L; Valdellon J; Borchelt D; Kelley K; Spielman L; Aisen PS; Pasinetti GM. 2002. Cyclooxygenase (COX)-2 and cell cycle activity in a transgenic mouse model of Alzheimer's disease neuropathology. Neurobiol Aging 23(3):327-34. PubMed: 11959394MGI: J:100961
- Xie H; Hou S; Jiang J; Sekutowicz M; Kelly J; Bacskai BJ. 2013. Rapid cell death is preceded by amyloid plaque-mediated oxidative stress. Proc Natl Acad Sci U S A 110(19):7904-9. PubMed: 23610434MGI: J:197345
- Yan P; Bero AW; Cirrito JR; Xiao Q; Hu X; Wang Y; Gonzales E; Holtzman DM; Lee JM. 2009. Characterizing the appearance and growth of amyloid plaques in APP/PS1 mice. J Neurosci 29(34):10706-14. PubMed: 19710322MGI: J:152312
- Yang Y; Cudaback E; Jorstad NL; Hemingway JF; Hagan CE; Melief EJ; Li X; Yoo T; Khademi SB; Montine KS; Montine TJ; Keene CD. 2013. APOE3, but Not APOE4, Bone Marrow Transplantation Mitigates Behavioral and Pathological Changes in a Mouse Model of Alzheimer Disease. Am J Pathol 183(3):905-17. PubMed: 23831297MGI: J:200093
- Yang Y; Shiao C; Hemingway JF; Jorstad NL; Shalloway BR; Chang R; Keene CD. 2013. Suppressed retinal degeneration in aged wild type and APPswe/PS1DeltaE9 mice by bone marrow transplantation. PLoS One 8(6):e64246. PubMed: 23750207MGI: J:204261
- Yuede CM; Lee H; Restivo JL; Davis TA; Hettinger JC; Wallace CE; Young KL; Hayne MR; Bu G; Li CZ; Cirrito JR. 2016. Rapid in vivo measurement of beta-amyloid reveals biphasic clearance kinetics in an Alzheimer's mouse model. J Exp Med 213(5):677-85. PubMed: 27069115MGI: J:233316
- Zhang J; Guo J; Zhao X; Chen Z; Wang G; Liu A; Wang Q; Zhou W; Xu Y; Wang C. 2013. Phosphodiesterase-5 inhibitor sildenafil prevents neuroinflammation, lowers beta-amyloid levels and improves cognitive performance in APP/PS1 transgenic mice. Behav Brain Res 250:230-7. PubMed: 23685322MGI: J:202125
- Zhang X; Li L; Zhang X; Xie W; Li L; Yang D; Heng X; Du Y; Doody RS; Le W. 2013. Prenatal hypoxia may aggravate the cognitive impairment and Alzheimer's disease neuropathology in APPSwe/PS1A246E transgenic mice. Neurobiol Aging 34(3):663-78. PubMed: 22795785MGI: J:194433
- Zhang XM; Cai Y; Xiong K; Cai H; Luo XG; Feng JC; Clough RW; Struble RG; Patrylo PR; Yan XX. 2009. Beta-secretase-1 elevation in transgenic mouse models of Alzheimer's disease is associated with synaptic/axonal pathology and amyloidogenesis: implications for neuritic plaque development. Eur J Neurosci 30(12):2271-83. PubMed: 20092570MGI: J:157228
- Zhang Y; Zhou B; Zhang F; Wu J; Hu Y; Liu Y; Zhai Q. 2012. Amyloid-beta induces hepatic insulin resistance by activating JAK2/STAT3/SOCS-1 signaling pathway. Diabetes 61(6):1434-43. PubMed: 22522613MGI: J:196823
- Zhou XW; Gustafsson JA; Tanila H; Bjorkdahl C; Liu R; Winblad B; Pei JJ. 2008. Tau hyperphosphorylation correlates with reduced methylation of protein phosphatase 2A. Neurobiol Dis 31(3):386-94. PubMed: 18586097MGI: J:138611
- van Groen T; Liu L; Ikonen S; Kadish I. 2003. Diffuse amyloid deposition, but not plaque number, is reduced in amyloid precursor protein/presenilin 1 double-transgenic mice by pathway lesions. Neuroscience 119(4):1185-97. PubMed: 12831872MGI: J:100957
Additional - Tg(PSEN1dE9)S9Dbo related
- Borchelt DR; Davis J; Fischer M; Lee MK; Slunt HH; Ratovitsky T; Regard J; Copeland NG; Jenkins NA; Sisodia SS; Price DL. 1996. A vector for expressing foreign genes in the brains and hearts of transgenic mice. Genet Anal 13(6):159-63. PubMed: 9117892MGI: J:80782
- Cai Y; Xue ZQ; Zhang XM; Li MB; Wang H; Luo XG; Cai H; Yan XX. 2012. An age-related axon terminal pathology around the first olfactory relay that involves amyloidogenic protein overexpression without plaque formation. Neuroscience 215:160-73. PubMed: 22542680MGI: J:192436
- Cayzac S; Mons N; Ginguay A; Allinquant B; Jeantet Y; Cho YH. 2015. Altered hippocampal information coding and network synchrony in APP-PS1 mice. Neurobiol Aging 36(12):3200-13. PubMed: 26391642MGI: J:232243
- Choi SH; Veeraraghavalu K; Lazarov O; Marler S; Ransohoff RM; Ramirez JM; Sisodia SS. 2008. Non-cell-autonomous effects of presenilin 1 variants on enrichment-mediated hippocampal progenitor cell proliferation and differentiation. Neuron 59(4):568-80. PubMed: 18760694MGI: J:149876
- Cirrito JR; Disabato BM; Restivo JL; Verges DK; Goebel WD; Sathyan A; Hayreh D; D'Angelo G; Benzinger T; Yoon H; Kim J; Morris JC; Mintun MA; Sheline YI. 2011. Serotonin signaling is associated with lower amyloid-{beta} levels and plaques in transgenic mice and humans. Proc Natl Acad Sci U S A 108(36):14968-73. PubMed: 21873225MGI: J:175216
- Collins JM; King AE; Woodhouse A; Kirkcaldie MT; Vickers JC. 2015. The effect of focal brain injury on beta-amyloid plaque deposition, inflammation and synapses in the APP/PS1 mouse model of Alzheimer's disease. Exp Neurol 267:219-29. PubMed: 25747037MGI: J:221130
- Dodson SE; Andersen OM; Karmali V; Fritz JJ; Cheng D; Peng J; Levey AI; Willnow TE; Lah JJ. 2008. Loss of LR11/SORLA enhances early pathology in a mouse model of amyloidosis: evidence for a proximal role in Alzheimer's disease. J Neurosci 28(48):12877-86. PubMed: 19036982MGI: J:142501
- El-Amouri SS; Zhu H; Yu J; Marr R; Verma IM; Kindy MS. 2008. Neprilysin: an enzyme candidate to slow the progression of Alzheimer's disease. Am J Pathol 172(5):1342-54. PubMed: 18403590MGI: J:134308
- Gao L; Chen X; Tang Y; Zhao J; Li Q; Fan X; Xu H; Yin ZQ. 2015. Neuroprotective effect of memantine on the retinal ganglion cells of APPswe/PS1DeltaE9 mice and its immunomodulatory mechanisms. Exp Eye Res 135:47-58. PubMed: 25912193MGI: J:230333
- Garcia-Alloza M; Dodwell SA; Meyer-Luehmann M; Hyman BT; Bacskai BJ. 2006. Plaque-derived oxidative stress mediates distorted neurite trajectories in the Alzheimer mouse model. J Neuropathol Exp Neurol 65(11):1082-9. PubMed: 17086105MGI: J:120918
- Hou Y; Aboukhatwa MA; Lei DL; Manaye K; Khan I; Luo Y. 2010. Anti-depressant natural flavonols modulate BDNF and beta amyloid in neurons and hippocampus of double TgAD mice. Neuropharmacology 58(6):911-20. PubMed: 19917299MGI: J:179562
- Jankowsky JL; Fadale DJ; Anderson J; Xu GM; Gonzales V; Jenkins NA; Copeland NG; Lee MK; Younkin LH; Wagner SL; Younkin SG; Borchelt DR. 2004. Mutant presenilins specifically elevate the levels of the 42 residue beta-amyloid peptide in vivo: evidence for augmentation of a 42-specific gamma secretase. Hum Mol Genet 13(2):159-70. PubMed: 14645205MGI: J:87691
- Jankowsky JL; Slunt HH; Gonzales V; Jenkins NA; Copeland NG; Borchelt DR. 2004. APP processing and amyloid deposition in mice haplo-insufficient for presenilin 1. Neurobiol Aging 25(7):885-92. PubMed: 15212842MGI: J:102351
- Jankowsky JL; Slunt HH; Ratovitski T; Jenkins NA; Copeland NG; Borchelt DR. 2001. Co-expression of multiple transgenes in mouse CNS: a comparison of strategies. Biomol Eng 17(6):157-65. PubMed: 11337275MGI: J:78664
- Jankowsky JL; Younkin LH; Gonzales V; Fadale DJ; Slunt HH; Lester HA; Younkin SG; Borchelt DR. 2007. Rodent A beta modulates the solubility and distribution of amyloid deposits in transgenic mice. J Biol Chem 282(31):22707-20. PubMed: 17556372MGI: J:124804
- Kamphuis W; Kooijman L; Orre M; Stassen O; Pekny M; Hol EM. 2015. GFAP and vimentin deficiency alters gene expression in astrocytes and microglia in wild-type mice and changes the transcriptional response of reactive glia in mouse model for Alzheimer's disease. Glia 63(6):1036-56. PubMed: 25731615MGI: J:221193
- Kanekiyo T; Cirrito JR; Liu CC; Shinohara M; Li J; Schuler DR; Shinohara M; Holtzman DM; Bu G. 2013. Neuronal clearance of amyloid-beta by endocytic receptor LRP1. J Neurosci 33(49):19276-83. PubMed: 24305823MGI: J:204149
- Kuchibhotla KV; Goldman ST; Lattarulo CR; Wu HY; Hyman BT; Bacskai BJ. 2008. Abeta plaques lead to aberrant regulation of calcium homeostasis in vivo resulting in structural and functional disruption of neuronal networks. Neuron 59(2):214-25. PubMed: 18667150MGI: J:145474
- Lagadec S; Rotureau L; Hemar A; Macrez N; Delcasso S; Jeantet Y; Cho YH. 2012. Early temporal short-term memory deficits in double transgenic APP/PS1 mice. Neurobiol Aging 33(1):203.e1-11. PubMed: 20817351MGI: J:188228
- Laird FM; Cai H; Savonenko AV; Farah MH; He K; Melnikova T; Wen H; Chiang HC; Xu G; Koliatsos VE; Borchelt DR; Price DL; Lee HK; Wong PC. 2005. BACE1, a major determinant of selective vulnerability of the brain to amyloid-beta amyloidogenesis, is essential for cognitive, emotional, and synaptic functions. J Neurosci 25(50):11693-709. PubMed: 16354928MGI: J:123534
- Lazarov O; Morfini GA; Pigino G; Gadadhar A; Chen X; Robinson J; Ho H; Brady ST; Sisodia SS. 2007. Impairments in fast axonal transport and motor neuron deficits in transgenic mice expressing familial Alzheimer's disease-linked mutant presenilin 1. J Neurosci 27(26):7011-20. PubMed: 17596450MGI: J:122975
- Lee GD; Aruna JH; Barrett PM; Lei DL; Ingram DK; Mouton PR. 2005. Stereological analysis of microvascular parameters in a double transgenic model of Alzheimer's disease. Brain Res Bull 65(4):317-22. PubMed: 15811597MGI: J:135436
- Lee MK; Borchelt DR; Kim G; Thinakaran G; Slunt HH; Ratovitski T; Martin LJ; Kittur A; Gandy S; Levey AI; Jenkins N; Copeland N; Price DL; Sisodian SS. 1997. Hyperaccumulation of FAD-linked presenilin 1 variants in vivo Nat Med 3(7):756-60. PubMed: 9212102MGI: J:104147
- Lesuisse C; Xu G; Anderson J; Wong M; Jankowsky J; Holtz G; Gonzalez V; Wong PC; Price DL; Tang F; Wagner S; Borchelt DR. 2001. Hyper-expression of human apolipoprotein E4 in astroglia and neurons does not enhance amyloid deposition in transgenic mice. Hum Mol Genet 10(22):2525-37. PubMed: 11709540MGI: J:72987
- Liu HL; Zhao G; Cai K; Zhao HH; Shi LD. 2011. Treadmill exercise prevents decline in spatial learning and memory in APP/PS1 transgenic mice through improvement of hippocampal long-term potentiation. Behav Brain Res 218(2):308-14. PubMed: 21192984MGI: J:168752
- Liu S; Liu Y; Hao W; Wolf L; Kiliaan AJ; Penke B; Rube CE; Walter J; Heneka MT; Hartmann T; Menger MD; Fassbender K. 2012. TLR2 is a primary receptor for Alzheimer's amyloid beta peptide to trigger neuroinflammatory activation. J Immunol 188(3):1098-107. PubMed: 22198949MGI: J:180762
- Liu Y; Yoo MJ; Savonenko A; Stirling W; Price DL; Borchelt DR; Mamounas L; Lyons WE; Blue ME; Lee MK. 2008. Amyloid pathology is associated with progressive monoaminergic neurodegeneration in a transgenic mouse model of Alzheimer's disease. J Neurosci 28(51):13805-14. PubMed: 19091971MGI: J:143521
- Luo H; Wu Q; Ye X; Xiong Y; Zhu J; Xu J; Diao Y; Zhang D; Wang M; Qiu J; Miao J; Zhang W; Wan J. 2014. Genome-wide analysis of miRNA signature in the APPswe/PS1DeltaE9 mouse model of alzheimer's disease. PLoS One 9(8):e101725. PubMed: 25148207MGI: J:221085
- Melnikova T; Savonenko A; Wang Q; Liang X; Hand T; Wu L; Kaufmann WE; Vehmas A; Andreasson KI. 2006. Cycloxygenase-2 activity promotes cognitive deficits but not increased amyloid burden in a model of Alzheimer's disease in a sex-dimorphic pattern. Neuroscience 141(3):1149-62. PubMed: 16753269MGI: J:111748
- Minett MS; Falk S; Santana-Varela S; Bogdanov YD; Nassar MA; Heegaard AM; Wood JN. 2014. Pain without nociceptors? Nav1.7-independent pain mechanisms. Cell Rep 6(2):301-12. PubMed: 24440715MGI: J:208794
- Oh ES; Savonenko AV; King JF; Fangmark Tucker SM; Rudow GL; Xu G; Borchelt DR; Troncoso JC. 2009. Amyloid precursor protein increases cortical neuron size in transgenic mice. Neurobiol Aging 30(8):1238-44. PubMed: 18304698MGI: J:152955
- Perez SE; Dar S; Ikonomovic MD; DeKosky ST; Mufson EJ. 2007. Cholinergic forebrain degeneration in the APPswe/PS1DeltaE9 transgenic mouse. Neurobiol Dis 28(1):3-15. PubMed: 17662610MGI: J:134818
- Perez SE; Lumayag S; Kovacs B; Mufson EJ; Xu S. 2008. {beta}-Amyloid Deposition and Functional Impairment in the Retina of the APPswe/PS1{Delta}E9 Transgenic Mouse Model of Alzheimer's Disease. Invest Ophthalmol Vis Sci 50(2):793-800. PubMed: 18791173MGI: J:139070
- Pistell PJ; Zhu M; Ingram DK. 2008. Acquisition of conditioned taste aversion is impaired in the amyloid precursor protein/presenilin 1 mouse model of Alzheimer's disease. Neuroscience 152(3):594-600. PubMed: 18304749MGI: J:135640
- Reinders NR; Pao Y; Renner MC; da Silva-Matos CM; Lodder TR; Malinow R; Kessels HW. 2016. Amyloid-beta effects on synapses and memory require AMPA receptor subunit GluA3. Proc Natl Acad Sci U S A 113(42):E6526-E6534. PubMed: 27708157MGI: J:238628
- Rodriguez JJ; Olabarria M; Chvatal A; Verkhratsky A. 2009. Astroglia in dementia and Alzheimer's disease. Cell Death Differ 16(3):378-85. PubMed: 19057621MGI: J:158080
- Sheline YI; West T; Yarasheski K; Swarm R; Jasielec MS; Fisher JR; Ficker WD; Yan P; Xiong C; Frederiksen C; Grzelak MV; Chott R; Bateman RJ; Morris JC; Mintun MA; Lee JM; Cirrito JR. 2014. An antidepressant decreases CSF Abeta production in healthy individuals and in transgenic AD mice. Sci Transl Med 6(236):236re4. PubMed: 24828079MGI: J:215342
- Soderman A; Mikkelsen JD; West MJ; Christensen DZ; Jensen MS. 2011. Activation of nicotinic alpha(7) acetylcholine receptor enhances long term potentation in wild type mice but not in APP(swe)/PS1DeltaE9 mice. Neurosci Lett 487(3):325-9. PubMed: 20974225MGI: J:168638
- Soderman A; Thomsen MS; Hansen HH; Nielsen EO; Jensen MS; West MJ; Mikkelsen JD. 2008. The nicotinic alpha7 acetylcholine receptor agonist ssr180711 is unable to activate limbic neurons in mice overexpressing human amyloid-beta1-42. Brain Res 1227:240-7. PubMed: 18619425MGI: J:139987
- Szapacs ME; Numis AL; Andrews AM. 2004. Late onset loss of hippocampal 5-HT and NE is accompanied by increases in BDNF protein expression in mice co-expressing mutant APP and PS1. Neurobiol Dis 16(3):572-80. PubMed: 15262269MGI: J:131666
- Tagawa K; Homma H; Saito A; Fujita K; Chen X; Imoto S; Oka T; Ito H; Motoki K; Yoshida C; Hatsuta H; Murayama S; Iwatsubo T; Miyano S; Okazawa H. 2015. Comprehensive phosphoproteome analysis unravels the core signaling network that initiates the earliest synapse pathology in preclinical Alzheimer's disease brain. Hum Mol Genet 24(2):540-58. PubMed: 25231903MGI: J:217304
- Tamboli IY; Prager K; Thal DR; Thelen KM; Dewachter I; Pietrzik CU; St George-Hyslop P; Sisodia SS; De Strooper B; Heneka MT; Filippov MA; Muller U; van Leuven F; Lutjohann D; Walter J. 2008. Loss of gamma-secretase function impairs endocytosis of lipoprotein particles and membrane cholesterol homeostasis. J Neurosci 28(46):12097-106. PubMed: 19005074MGI: J:142399
- Tang J; Song M; Wang Y; Fan X; Xu H; Bai Y. 2009. Noggin and BMP4 co-modulate adult hippocampal neurogenesis in the APP(swe)/PS1(DeltaE9) transgenic mouse model of Alzheimer's disease. Biochem Biophys Res Commun 385(3):341-5. PubMed: 19463786MGI: J:150675
- Thinakaran G; Borchelt DR; Lee MK; Slunt HH; Spitzer L; Kim G; Ratovitsky T; Davenport F; Nordstedt C; Seeger M; Hardy J; Levey AI; Gandy SE; Jenkins NA; Copeland NG; Price DL; Sisodia SS. 1996. Endoproteolysis of presenilin 1 and accumulation of processed derivatives in vivo. Neuron 17(1):181-90. PubMed: 8755489MGI: J:34323
- Turdi S; Guo R; Huff AF; Wolf EM; Culver B; Ren J. 2009. Cardiomyocyte contractile dysfunction in the APPswe/PS1dE9 mouse model of Alzheimer's disease. PLoS One 4(6):e6033. PubMed: 19551139MGI: J:150191
- Veeraraghavalu K; Choi SH; Zhang X; Sisodia SS. 2010. Presenilin 1 mutants impair the self-renewal and differentiation of adult murine subventricular zone-neuronal progenitors via cell-autonomous mechanisms involving notch signaling. J Neurosci 30(20):6903-15. PubMed: 20484632MGI: J:160514
- Veeraraghavalu K; Sisodia SS. 2013. Mutant presenilin 1 expression in excitatory neurons impairs enrichment-mediated phenotypes of adult hippocampal progenitor cells. Proc Natl Acad Sci U S A 110(22):9148-53. PubMed: 23674689MGI: J:197420
- Veeraraghavalu K; Zhang C; Zhang X; Tanzi RE; Sisodia SS. 2014. Age-dependent, non-cell-autonomous deposition of amyloid from synthesis of beta-amyloid by cells other than excitatory neurons. J Neurosci 34(10):3668-73. PubMed: 24599465MGI: J:209619
- Verret L; Jankowsky JL; Xu GM; Borchelt DR; Rampon C. 2007. Alzheimer's-type amyloidosis in transgenic mice impairs survival of newborn neurons derived from adult hippocampal neurogenesis. J Neurosci 27(25):6771-80. PubMed: 17581964MGI: J:122001
- Wang X; Liu P; Zhu H; Xu Y; Ma C; Dai X; Huang L; Liu Y; Zhang L; Qin C. 2009. miR-34a, a microRNA up-regulated in a double transgenic mouse model of Alzheimer's disease, inhibits bcl2 translation. Brain Res Bull 80(4-5):268-73. PubMed: 19683563MGI: J:186827
- Yan P; Bero AW; Cirrito JR; Xiao Q; Hu X; Wang Y; Gonzales E; Holtzman DM; Lee JM. 2009. Characterizing the appearance and growth of amyloid plaques in APP/PS1 mice. J Neurosci 29(34):10706-14. PubMed: 19710322MGI: J:152312
- Yang Y; Cudaback E; Jorstad NL; Hemingway JF; Hagan CE; Melief EJ; Li X; Yoo T; Khademi SB; Montine KS; Montine TJ; Keene CD. 2013. APOE3, but Not APOE4, Bone Marrow Transplantation Mitigates Behavioral and Pathological Changes in a Mouse Model of Alzheimer Disease. Am J Pathol 183(3):905-17. PubMed: 23831297MGI: J:200093
- Yang Y; Shiao C; Hemingway JF; Jorstad NL; Shalloway BR; Chang R; Keene CD. 2013. Suppressed retinal degeneration in aged wild type and APPswe/PS1DeltaE9 mice by bone marrow transplantation. PLoS One 8(6):e64246. PubMed: 23750207MGI: J:204261
- Yuede CM; Lee H; Restivo JL; Davis TA; Hettinger JC; Wallace CE; Young KL; Hayne MR; Bu G; Li CZ; Cirrito JR. 2016. Rapid in vivo measurement of beta-amyloid reveals biphasic clearance kinetics in an Alzheimer's mouse model. J Exp Med 213(5):677-85. PubMed: 27069115MGI: J:233316
- Zhang X; Garbett K; Veeraraghavalu K; Wilburn B; Gilmore R; Mirnics K; Sisodia SS. 2012. A Role for Presenilins in Autophagy Revisited: Normal Acidification of Lysosomes in Cells Lacking PSEN1 and PSEN2. J Neurosci 32(25):8633-48. PubMed: 22723704MGI: J:185660
- Zhang XM; Cai Y; Xiong K; Cai H; Luo XG; Feng JC; Clough RW; Struble RG; Patrylo PR; Yan XX. 2009. Beta-secretase-1 elevation in transgenic mouse models of Alzheimer's disease is associated with synaptic/axonal pathology and amyloidogenesis: implications for neuritic plaque development. Eur J Neurosci 30(12):2271-83. PubMed: 20092570MGI: J:157228